Posted on January 25, 2021 by Sitemaster
It is becoming very clear that over the next 5 to 10 years we will develop a whole new spectrum of urine-based tests for the assessment of risk for prostate cancer and whether a specific patient will actually need a biopsy and/or other tests to confirm diagnosis. … READ MORE…
Filed under: Diagnosis, Risk | Tagged: future, risk, screening, test, urine | 1 Comment »
Posted on November 12, 2020 by Sitemaster
So our good friend Howard Wolinsky has just written up his assessment on the evolution of the use of the PSA test in “screening” for prostate cancer in an article on the MedPage Today web site. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, test | 17 Comments »
Posted on June 26, 2020 by Sitemaster
A newly published article by Shoag et al. in the New England Journal of Medicine (NEJM) has suggested that the risks associated with “screening” for prostate cancer using the PSA test may not be as high as previously suggested. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: benefit, PSA, risk, screening, test | 4 Comments »
Posted on March 4, 2020 by Sitemaster
Jane Brody is an experienced journalist who writes regularly about issues related to health care in The New York Times. Your sitemaster regularly reads her columns because she does her homework with care and provides sound information for her readers. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, Brody, New York Times, screening, surveillance | 11 Comments »
Posted on January 10, 2019 by Sitemaster
A newly published paper in the Journal of Clinical Oncology has confirmed — based on a prospective study (as opposed to retrospective data) — that there is a strong risk association between a germline mutation of the BRCA2 gene and risk for metastatic castration-resistant prostate cancer (mCRPC). … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: BRCA2, germline, mutation, screening | 1 Comment »
Posted on January 4, 2019 by Sitemaster
Our regular readers will remember that we have commented on and off on the development of different types of system that (maybe) can be used to test for risk of cancer based on smell … an ability that has been clearly demonstrated among certain trained dogs and one of two electronic systems. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: breath, cancer, Diagnosis, risk, screening, smell | Leave a comment »
Posted on October 10, 2018 by Sitemaster
A recent report from the Prostate Cancer Foundation (PCF), here in the US, found — unsurprisingly to your sitemaster, at least — that the average American remains very poorly informed about risk for prostate cancer and associated issues. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: education, public, risk, screening, testing | 2 Comments »
Posted on September 18, 2018 by Sitemaster
A new and potentially controversial article in Urology (the “Gold Journal”) has just suggested that regular, mass, population-based screening of men for risk of prostate cancer every 12 to 18 months remains a good idea. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Management, PSA, risk, screening, testing | 9 Comments »
Posted on September 7, 2018 by Sitemaster
… and during Prostate Cancer Awareness Month men and their families are regularly subjected to messaging about the importance of getting “screened” for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: risk, screening, testing | 4 Comments »
Posted on May 8, 2018 by Sitemaster
The following infographic was also issued today by the U.S. Preventive Services Task Force (USPSTF) and offers guidance as to the appropriateness of prostate cancer screening for an average, 55- to 69-year-old American male with no specific, known risk factors for prostate cancer: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: cancer, infographic, prostate, risk, screening | 8 Comments »
Posted on May 8, 2018 by Sitemaster
Earlier today, the US Preventive Services Task Force (USPSTF) issued the final version of its revised guidance on screening for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: recommendation, screening, USPSTF | 6 Comments »
Posted on April 17, 2018 by Sitemaster
According to a recent report in the American Journal of Preventive Medicine, only 5.6 percent of a sample of 3,677 Americans of 18 years of age or older could correctly evaluate four simple statements about cancer screening. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: comprehension, knowledge, screening | Leave a comment »
Posted on March 7, 2018 by Sitemaster
A while ago now we had first mentioned the “Cluster randomized trial of PSA testing for prostate cancer” or CAP trial — the single largest randomized trial of PSA screening for risk of prostate cancer to be implemented. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, test | 18 Comments »
Posted on November 19, 2017 by Sitemaster
Our friends at UroToday have just published a perfectly lovely lecture on this topic given by Prof. Lenny Gomella at the recent annual meeting of the Large Urology Group Practice Association (LUGPA). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, genetics, genomics, prognosis, screening, Treatment | 7 Comments »
Posted on September 18, 2017 by Sitemaster
The European Association of Urology (EAU) “Update on Prostate Cancer” meeting was held in Vienna, Austria, on Friday and Saturday, and Dr. Zachary Klaassen was again busy providing summary reports on presentations for UroToday. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: active surveillance, Diagnosis, PSA, screening, staging, testing | Leave a comment »